Skip to main content
. Author manuscript; available in PMC: 2011 Jan 1.
Published in final edited form as: Ophthalmology. 2009 Oct 8;117(1):128. doi: 10.1016/j.ophtha.2009.06.016

Figure 2.

Figure 2

Survival from development of resistant cytomegalovirus (CMV) for patients with CMV retinitis, comparing patients in the pre-HAART* and HAART eras.

*HAART = highly active antiretroviral therapy.